One Adamax certificate we checked says the molecule weighs 1032.3. The graph on the same page says 984.6.
Both numbers can’t be right. They belong to two different molecules: Adamax, and a lookalike without its adamantane group. The sheet still marks identity “Conforms.”
A purity percentage can’t tell the two apart. A mass spectrum can. This page shows you how to read one, using two real certificates, then covers what you came to check: what Adamax is, what research exists (we found none on Adamax itself), and where the law stands.
Adamax is sold for research use only. It is not approved for human use anywhere we checked (as of October 2026), and nothing here is medical advice or covers how anyone would use it.
Adamax at a glance
| Question | What we found (as of October 2026) | How sure we are |
|---|---|---|
| What is it? | N-acetyl Semax plus an adamantane group and a C-terminal amide. Molecular weight: 1,032.2 g/mol. | Solid |
| Has anyone studied it? | No study of Adamax on PubMed (searched 17 October 2026). The evidence comes from Semax (human and animal) and Peptide 021 (mice and rats). | None for Adamax |
| Is it safe? | No safety data from any trial. User reports are anecdotes, not measured rates. | Unknown |
| Is it approved? | Not FDA-approved. We found no country that has approved it. | Checked |
| Can a certificate prove what is in the vial? | Only for that lot, and only if it shows a mass spectrum that matches. One certificate printed 1032.3 while its own spectrum peaked at 984.6. | Check it yourself |
Jump to: What it is Check a COA Research Risks Legal status FAQ
What is Adamax peptide?
Adamax is a modified version of Semax, a fragment of the hormone ACTH. The modification adds an adamantane group, meant to help the molecule resist breakdown and reach the brain. Whether it does has not been measured.
It is sold for research purposes only, with claims about attention, memory and neuroprotection. Vendors sell it as a liquid or as freeze-dried powder (lyophilized). New to peptides? Start with What Are Peptides? A Plain-English Guide.
How Adamax is built
Adamax keeps Semax’s seven-amino-acid chain and adds two end-modifications used in Peptide 021, a neurotrophic research molecule developed by the Iqbal lab in New York (see Bolognin 2014 in Sources):
- N-terminal acetylation (Ac-). A chemical cap on the front of the molecule, meant to keep body enzymes from trimming it off.
- An adamantane amide residue. Adamantane is a fat-soluble, rigid carbon cage. Peptide 021 uses a similar adamantane modification to try to help a peptide stay intact and reach the brain. Its effects have been reported in mice.
Adamax, Adamax 1032 and DW 1032: same compound?
Yes, with one catch. The number 1032 is the molecular weight, and vendors appear to add it to the name to signal the complete molecule. At least one certificate we checked describes a lookalike without the adamantane group sold under the Adamax name.
| Name you’ll see | What it means |
|---|---|
| Adamax | The full molecule: Ac-MEHFPGP + adamantane residue + amide, 1,032.2 g/mol |
| Adamax 1032 / Adamax-1032 | Same compound. The number is the molecular weight in g/mol (daltons) |
| DW 1032 | A vendor label that appears to name the same compound |
| Adamax adamantane / adamantane Semax | Descriptive names vendors use for the same compound |
| “Adamax” at 984 Da | A different molecule: acetyl-Semax plus alanine and glycine, with no adamantane. See the COA section |
How to check an Adamax COA: the mass spectrum test
A 99% HPLC purity figure shows that a powder is mostly one substance. It does not say which substance. Mass spectrometry does, and Adamax’s numbers are easy to read.
| Compound | Formula | Expected [M+H]+ | Expected [M+2H]2+ |
|---|---|---|---|
| Adamax (real) | C50H69N11O11S | 1,032.5 | 516.8 |
| Ac-MEHFPGP-Ala-Gly (984 lookalike) | C44H61N11O13S | 984.4 | 492.7 |
| Semax | C37H51N9O10S | 814.4 | 407.7 |
What two real Adamax certificates show
| Detail | True Lab Peptides | American Peptides |
|---|---|---|
| Certificate | True Lab Peptides, lot AMX10L0 | American Peptides, report COA7596 |
| Lab and date | Freedom Diagnostics, reported 29 June 2026 | Bioviridian, issued 17 August 2026 |
| Lot | AMX10L0 | ADA10-0803 |
| Spectrum peaks | 1,032.3 and 516.8 | 984.6 and 492.8 |
| What those peaks match | The full Adamax molecule Match | The lookalike without adamantane No match |
The American Peptides sheet prints “MW 1032.3” and marks identity “Conforms,” yet its own spectrum peaks at 984.6 and 492.8. We don’t know why: it could be a template or labeling error, or a different molecule. One certificate describes one lot. It doesn’t show what any other lot from the same vendor contains, or what was in any vial.
COA checklist for Adamax
| Check | A good certificate shows | Red flag |
|---|---|---|
| Mass spectrum | Printed on the certificate | Only a purity percentage |
| Peaks | About 1,032 and 516 to 517 | 984 and 492: the adamantane is missing |
| Lot number | Matches your vial, and the lab offers online verification | No lot number, or no way to verify it |
| Net content | A percentage of the label amount, close to what the label says | Missing, or far from the label amount |
| Endotoxin and sterility | Results printed | Not tested: contamination is a possible risk of an unverified vial |
A worked example: NextGen Peptides, lot NSP-ADMX-01
We ran this listing’s lab report through the checklist above. Here is what it shows, and what it doesn’t.
| Check | What the report shows | Against the checklist |
|---|---|---|
| Identity | HPLC retention-time match against a reference standard. No mass spectrum. | No spectrum |
| Lot and lab | ILS Laboratories (ISO/IEC 17025), lot NSP-ADMX-01, with an online verification code. | Verifiable |
| Net content and purity | 106% of the label amount (three samples: 104.7% to 106.1%). Purity 99.47%. | 6% over label |
| Contamination screens | Sterility (PCR): “No Growth,” the report’s own wording. Endotoxin: 0.16 EU/mL (a result, but no limit given). Heavy metals within limits. | Partial |
| Tested | July 2026. |
Check current price and lot (the report above shows no mass spectrum)
A COA covers one lot and one lab. It does not make an unapproved product suitable for human use. For a full walkthrough, see how to read a peptide COA. To see which vendors we rank and which we don’t, read our peptide scams to avoid and best peptide vendors pages.
What research shows
We found no Adamax research. PubMed shows no Adamax peptide studies as of 17 October 2026, and we found no information on side effects either. New Zealand’s medicines regulator says there seems to be limited clinical research on the benefits.
What exists is research on its two parents:
How to read it. Human small study: a small human report. Animal: animal work only. None: no study found.
| Claimed Adamax benefit | Compound actually studied | Evidence | Source | Grade |
|---|---|---|---|---|
| Raises BDNF (a brain growth factor) | Semax, intranasal | Rats | Dolotov 2006 | Animal |
| Activates neurotrophin genes after brain injury | Semax | Rats (stroke model) | Dmitrieva 2010 | Animal |
| Stroke recovery | Semax | Humans: 30 patients vs 80 controls, no randomization described | Gusev 1997 | Human small study |
| Anti-inflammatory, vascular effects | Semax | Rats (gene expression) | Medvedeva 2014 | Animal |
| Mood, stress resilience | Semax | Rats (chronic stress model) | Inozemtseva 2024 | Animal |
| Memory, learning, neurogenesis | Peptide 021 (adamantane) | Mice | Li 2010 | Animal |
| Protection against cognitive ageing | Peptide 021 | Aged rats | Bolognin 2014 | Animal |
| Adamax itself, any outcome | Adamax | None found | PubMed, 17 Oct 2026 | None |
What that evidence can and can’t tell you
In animal studies, Semax activates BDNF and neurotrophin signaling. That is evidence about Semax, not Adamax. Peptide 021 improved learning and neurogenesis in mice and aged rats. It shows the adamantane modification can be applied to a peptide other than Semax. It does not show that Adamax does anything.
We found no study that tested Adamax against any of these claims, and no data on its effects in men or in women.
Adamax side effects, risks and unknowns
We found no safety data from any trial of Adamax. The items below are what users and vendors report. They are anecdotes, not measured rates (ANECDOTAL).
Reported by users and vendor guides: headache, nasal irritation with sprays, restlessness or mild anxiety, poor sleep, fatigue and nausea.
Unknown: long-term effects of any kind, interactions with psychiatric or other medication, effects in pregnancy, breastfeeding or under-18s, and contamination or a wrong compound (see the COA section).
Adamax’s own risks are unknown. One risk you can check today is what is in the vial. At least one certificate we checked describes a different molecule under the Adamax name, as the next section shows.
Can Adamax cause cancer?
Nobody knows. We found no long-term studies of Adamax. Its parent, Semax, is reported to act on BDNF and neurotrophin signaling in rats, and growth-signaling pathways are the reason people ask the cancer question about brain-active peptides. Whether that concern applies to Adamax has never been tested, so this is neither a finding of harm nor a finding of safety (UNSUPPORTED either way). Anyone with a history of cancer should talk to a doctor before using any research peptide.
Is Adamax legal?
| Where | Status (as of October 2026) |
|---|---|
| United States | Adamax is not FDA-approved and is sold only as a research chemical. In July 2026 an FDA advisory committee voted yes on six peptides for pharmacy compounding, among them BPC-157 and KPV. The vote was non-binding. We found no FDA approval, and no compounding decision, covering Adamax (as of October 2026). (STAT, 23 July 2026; Buchanan Ingersoll & Rooney) |
| New Zealand | In a June 2025 submission to its Medicines Classification Committee, Medsafe recommended classifying ACTH analogues, with Adamax and Semax named as examples, as prescription medicines. It noted limited clinical research on their benefits. That was a recommendation, and we have not confirmed the committee’s final decision. |
| Elsewhere | We found no country that has approved Adamax (as of October 2026). Check your local rules. |
What we know, what we don’t, and what would change our confidence
| Topic | Details |
|---|---|
| Known | Adamax is Semax plus an adamantane group and an amide, 1,032.2 g/mol. We found no study of Adamax and no approval in any country. At least one certificate shows a 984 g/mol lookalike under the Adamax name. |
| Unknown | Whether Adamax does anything in any species. Its safety. Whether the adamantane group improves stability, which has not been measured. Long-term and cancer risk. Interactions. |
| What would change our confidence | A published study of Adamax itself. An independent lab reporting the mass for a named lot. A regulator’s decision. |
Who should not use this
Not for: under 18, tested athletes (check WADA and NCAA lists) and pregnancy. If you have a history of cancer, take psychiatric medication, or are breastfeeding, talk to a doctor first. This page can’t tell you whether any research peptide is right for you.
Adamax peptide FAQ
What is Adamax used for?
Adamax is sold for research on focus, memory and neuroprotection. It has no approved medical use, and we found no study that tested it for any of these. The claims come from Semax and Peptide 021 research.
What is Adamax and Adalank?
Adalank is sold by the same vendors as a Selank analogue, the way Adamax is a Semax analogue. We found no published studies on either. Semax and Selank are compared in our Semax vs Selank guide.
Is Adamax better than Semax?
Nobody knows. Semax has been studied mostly in Russia, where it is registered as a drug, and that evidence is limited by US trial standards. We found no studies of Adamax. The adamantane group may improve stability, but that hasn’t been measured.
Is Adamax an alternative to Adderall, modafinil or ADHD medication?
No. Adderall and modafinil are approved stimulant-type drugs with large bodies of trial data. Adamax is an unapproved research peptide, and we found no ADHD studies of it. We found Semax proposed for ADHD only in a theoretical paper (Tsai 2006).
How does Adamax compare with Cerebrolysin or NAD+?
They’re unrelated. Cerebrolysin is a pig-brain peptide mixture used clinically in some countries, and NAD+ is a metabolic coenzyme (see our NAD+ guide). None has been compared with Adamax in a study.
Is Adamax safe?
Unknown. We found no safety trials, only anecdotal user reports of headache, nasal irritation, restlessness and poor sleep. Its own risks are unknown. One risk you can check is getting the wrong compound, so check the mass on the COA.
Does Adamax need to be refrigerated?
Vendors recommend keeping the powder cold and away from heat and light. No published stability data exist for Adamax, so treat storage advice as a vendor claim.
Before you trust a vial
We found no studies, no approval and no safety data for Adamax. The one thing a reader can check is the certificate. If its spectrum peaks near 984 instead of 1,032, the certificate doesn’t match the molecule it names, and the identity of the vial is unconfirmed. If a vendor can’t show a spectrum, treat the identity as unconfirmed too.
Sources
- Adamax, Wikipedia (structure, formula, molar mass)
- Medsafe, Classification of unscheduled peptides, June 2025
- Li B, et al. FEBS Lett. 2010
- Bolognin S, et al. Neurobiol Aging. 2014
- Dolotov OV, et al. J Neurochem. 2006
- Dmitrieva VG, et al. Cell Mol Neurobiol. 2010
- Medvedeva EV, et al. BMC Genomics. 2014
- Gusev EI, et al. Zh Nevrol Psikhiatr. 1997 (PMID 11517472)
- Inozemtseva LS, et al. Eur J Pharmacol. 2024
- Tsai SJ. Med Hypotheses. 2006
- STAT, 23 July 2026
- Buchanan Ingersoll & Rooney
- Vendor certificates: True Lab Peptides AMX10L0; American Peptides COA7596; NextGen NSP-ADMX-01
- Community sources (anecdotal): PeptideMind; PeptIQ; Derek’s Research Radar; Krysia